FDA Says Merck COVID Pill Effective, Experts To Review Safety

Merck's antiviral pill is effective against the current virus, reducing hospitalization or death risk by 30% among adults with mild or moderate disease. However, the effectiveness is less than previously estimated. The company seeks expert opinions on potential risks for pregnant women, including birth defects. In trials, 9 deaths occurred in the placebo group, while only one death was reported among those taking the pill.

What was the previous estimate of the pill's effectiveness compared to the latest results?

How many deaths were reported in the group receiving a placebo compared to those given the pill?